Share Facebook Twitter LinkedIn Pinterest Email Eli Lilly chairman and CEO David Ricks joins CNBC’s “Squawk on the Street” team to discuss its quarterly earnings report that beat estimates, weight loss drug demand, its drug pipeline and more.